JAFL
AGN

Jay A. Fishman Ltd’s Allergan plc AGN Stock Holding History

Jay A. Fishman Ltd’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,830
Closed -$1.15M – 97
2020
Q1 		$1.15M Buy
7,830
+5,680
+264% +$1.07M 0.12% 57
2019
Q4 		$411K Buy
2,150
+160
+8% +$28.9K 0.07% 65
2019
Q3 		$335K Sell
1,990
-5,300
-73% -$863K 0.06% 65
2019
Q2 		$1.22M Sell
7,290
-540
-7% -$74.8K 0.23% 46
2019
Q1 		$1.15M Buy
7,830
+1,500
+24% +$217K 0.21% 48
2018
Q4 		$846K Sell
6,330
-1,500
-19% -$246K 0.18% 51
2018
Q3 		$1.49M Sell
7,830
-300
-4% -$55.1K 0.26% 43
2018
Q2 		$1.36M Sell
8,130
-3,650
-31% -$586K 0.25% 44
2018
Q1 		$1.98M Sell
11,780
-14,794
-56% -$2.48M 0.37% 41
2017
Q4 		$4.35M Sell
26,574
-56,123
-68% -$10.1M 0.82% 27
2017
Q3 		$16.9M Sell
82,697
-2,125
-3% -$494K 3.46% 10
2017
Q2 		$20.6M Sell
84,822
-102
-0.1% -$24K 4.37% 8
2017
Q1 		$20.3M Buy
84,924
+25,380
+43% +$5.91M 4.58% 7
2016
Q4 		$12.5M Sell
59,544
-41,054
-41% -$8.5M 3.09% 10
2016
Q3 		$23.2M Sell
100,598
-5,765
-5% -$1.41M 5.71% 4
2016
Q2 		$24.6M Buy
106,363
+33,105
+45% +$7.63M 6.23% 3
2016
Q1 		$19.6M Buy
73,258
+14,450
+25% +$4.14M 5.11% 2
2015
Q4 		$18.4M Buy
58,808
+15,653
+36% +$4.66M 4.47% 6
2015
Q3 		$11.7M Buy
43,155
+6,470
+18% +$1.99M 2.81% 12
2015
Q2 		$11.1M Buy
36,685
+10,385
+39% +$3.1M 2.31% 14
2015
Q1 		$7.83M Buy
+26,300
New +$7.5M 1.64% 22

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Jay A. Fishman Ltd's AGN Position: Q2 2020 in Review

Jay A. Fishman Ltd sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,830 shares — an estimated $1.15M sold.

Jay A. Fishman Ltd first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $24.6M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Jay A. Fishman Ltd reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 7,830 Allergan plc shares in Q2 2020, an estimated $1.15M.
  • Jay A. Fishman Ltd first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • Jay A. Fishman Ltd's Allergan plc position peaked at $24.6M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Jay A. Fishman Ltd's 13F filing for Q2 2020, filed 10 Aug 2020.